Medication info
Ducor Tablet 60/5 mg

Ducor Tablet 60/5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
Korea Nelson Pharmaceutical Co., Ltd.
Appearance
Orange rectangular film-coated tablet with rounded corners
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300101 · Approved 2023.01.06

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 milligrams. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Ingredients

Manufacturer
Korea Nelson Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used as an add-on treatment for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy, effectively lowering and controlling blood pressure. This helps reduce the risk of cardiovascular diseases and aids in blood pressure management.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 milligrams. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's active ingredients or similar class medications, pregnant or lactating women, patients undergoing renal dialysis, patients with severe liver impairment, patients with obstructed bile ducts, certain renal and diabetic patients, lactose intolerant patients, patients with severe aortic stenosis, and those in a state of shock should not take this medication. Patients with low blood volume or sodium, impaired kidney function, renal artery hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and those with allergies to specific pigments should use this medication cautiously. Side effects such as dizziness, headache, facial swelling, urination disorders, insomnia, and flushing may occur while taking this medication; in rare cases, serious kidney problems or blood pressure drops may arise, necessitating immediate consultation with a healthcare provider if abnormal symptoms manifest. Patients with hypotension or electrolyte imbalances should be closely monitored during early treatment, as there is a risk of excessive blood pressure reduction. This medication may interact with other antihypertensive agents, certain diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc.; thus, it is crucial to inform healthcare providers of any other medications taken concurrently. Pregnant and lactating women should consult a physician before taking this medication and are advised to avoid it whenever possible. The safety and efficacy of this medication has not been established in children and adolescents under 18 years of age; therefore, use is not recommended. Elderly patients do not require special dosage adjustments, but may have heightened sensitivity, so caution is necessary. Patients with severely impaired liver function should not take this medication, and in the case of overdose, immediate emergency measures should be obtained due to the potential for severe hypotension or cardiac issues. This medication should be kept out of reach of children and should not be transferred to another container, as it may compromise quality.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urination disorder
  • insomnia
  • flushing
  • syncope
  • sedation
Show 160 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contractions
  • musculoskeletal rigidity
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • bowel obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • deterioration of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colon carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • low back pain
  • edema
  • limb pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • epistaxis
  • bronchitis
  • sensory disturbance
  • numbness
  • tremors
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional bowel disease
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • frequency of urination
  • incontinence
  • kidney stones
  • chronic renal failure
  • shingles
  • panic response
  • Alzheimer's disease
  • suicide attempt
  • agitation
  • hyperthyroidism
  • hypothyroidism
  • increased TSH
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • blood pressure variability
  • fatty liver
  • postoperative pain
  • allergy
  • chills
  • nasal polyps
  • pulmonary tuberculosis
  • armpit pain
  • periorbital edema
  • sweating
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • ringing in the ears
  • visual disturbances
  • increased urination frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • vascular edema
  • polymorphic dermatosis
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • loose stools
  • skin erythema
  • maculopapular rash
  • dizziness
  • heat sensation
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; therefore, it should be stored in a container that blocks light. Additionally, it is important to store the medication at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Orange rectangular film-coated tablet with rounded corners

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.